Objective: The objective is to review the evidence evaluating the efficacy of statin therapy for
primary prevention of cardiovascular (CV) disease in the elderly. Data Sources: A literature …

BACKGROUND:: Although statins have been demonstrated to be beneficial for secondary
prevention in the elderly, their use for primary prevention has not been well described …

In the much older population (≥ 80 years), the management of cardiovascular diseases
requires specific research to avoid a plain transposition of medical practice from younger …

Statins have been demonstrated to be beneficial for secondary prevention of cardiovascular
(CV) events also in the elderly. However, a great debate is ongoing about the actual …

Method Methodic review of large randomized clinical trials and meta-analyzes that included
patients 75 years and older treated with statins in primary prevention. Results Since the …

Focuses on the use of statins in older people to prevent cardiovascular event. Estimation of
the risk reduction of coronary heart disease (CHD) and total mortality associated with statin …

Background Statins have been shown to be beneficial in primary and secondary prevention
settings; however, their role in the elderly remains a clinical conundrum, given that age …

An aging population brings considerable challenges for health care systems. The increase
in disease burden and economic investment required for the care of older patients is in …

Objectives The benefits of initiating statins in the elderly remains debated. We evaluated the
effects of initiating statins in the elderly, according to cardiovascular risk. Methods This …

Cardiovascular disease (CVD) is the leading cause of death, with a higher prevalence in
older adults who form an increasing proportion of the population of the United States. Statin …